Pharma News
Looking out for latest news on Pharma Magazine?
Check out the latest Pharma news, Top news in Pharma Magazine, Leading Magazine in Pharma industry. Daily news updates pertinent to the industrial sectors we are engaged with are depicted on the news section of Pharma industry which we operate.
SCIEX Localizes XR QTOF and ZenoTOF Systems in China to Advance Life Science Analytical Capabilities
Wednesday, March 04, 2026SCIEX announces the localization of its XR QTOF system ZenoTOF system and ZenoTOF system in China enhancing accessibility for Asian pharma RD and manufacturing
Antengene Enters into Agreement with UCB ATG-201 Targeting Autoimmune Diseases
Wednesday, March 04, 2026Antengene and UCB have entered into a global exclusive licence agreement for ATG a CDCD bispecific Tcell engager TCE being developed for the treatment of autoimmune diseases
Sinopia Biosciences Enters into Collaboration with Ono Pharmaceutical for Rare Metabolic Disorders
Wednesday, March 04, 2026Sinopia Biosciences has announced a target discovery collaboration with Ono Pharmaceutical focused on a group of rare metabolic disorders with significant unmet medical need
Sanofi’s Rilzabrutinib Receives Orphan Drug Status for IgG4-Related Disease
Tuesday, March 03, 2026Sanofi has announced that Japans Ministry of Health Labour and Welfare MHLW has granted orphan drug designation to rilzabrutinib for the treatment of IgGrelated disease IgGRD
Largest Pharma Show in Asia CPHI & PMEC China 2026 Returns to Shanghai
Tuesday, March 03, 2026The premier pharmaceutical exhibition in Asia CPHI PMEC China is scheduled to return to Shanghai from June to fostering global industry connections
Novo Nordisk to Invest Over US$505 million (€400 million) to Expand Athlone Manufacturing Facility in Ireland
Tuesday, March 03, 2026Novo Nordisk has announced an investment of million approximately million or DKK billion to expand its manufacturing facility in Monksland Athlone Ireland
PharmaEssentia Announces Japan Approval of High-Dose Dosing Regimen for BESREMi®
Tuesday, March 03, 2026PharmaEssentia has announced that Japans Ministry of Health Labour and Welfare MHLW has approved a highdose dosing regimen for ropeginterferon alfab marketed as BESREMi as an alternative schedule in the product label
Akeso Inc Secures NMPA Approval for Novel Bispecific Antibody Targeting Alzheimer's Disease in China
Monday, March 02, 2026Akeso Incs innovative bispecific antibody AK targeting amyloidbeta and the bloodbrain barrier receptor has received approval from Chinas National Medical Products Administration marking a breakthrough in Alzheimers therapy development
Targeted Partnering & Licensing Summit Asia: Global Exposure, Local Advantage in Tokyo
Friday, February 27, 2026The Targeted Therapies Partnering Licensing Summit Asia unites biopharma leaders in Tokyo on February to drive highvalue licensing deals in oncology and immunology therapies
Boehringer Ingelheim Receives FDA Approval for HERNEXEOS® for HER2-Mutant Advanced NSCLC
Friday, February 27, 2026Boehringer Ingelheim has received approval from the US Food and Drug Administration FDA for HERNEXEOS zongertinib tablets as the first targeted therapy for adult patients with HER ERBBmutant advanced nonsmall cell lung cancer NSCLC to be used as an i...
